Agreement
-
Spine
Oxford Performance Materials Announces Agreement with Fuse Medical to Develop New Spinal and Sports Medicine Implants
Fuse to Utilize OPM’s OsteoFab® Technology for Development of Unique 3D Printed PEKK Product Lines. SOUTH WINDSOR, CONN. (PRWEB) JULY 05,…
Read More » -
Financial
Bioventus Amends CartiHeal Acquisition Structure
DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical
Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System™ WARSAW, Ind., June 14,…
Read More » -
Biologics
Orthofix and MTF Biologics Expand Partnership Agreement
May 3, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical
Aurora Spine’s DEXA Technology patient-matched implants supported by Echolight’s newest technologies in bone health assessment CARLSBAD, Calif., Feb. 24, 2022…
Read More » -
Spine
OsteoCentric Technologies introduces THEIR Mechanical Integration UnifiMI technology to the $7.6b spinal fusion market
Mechanical Integration, the first new method to secure implants to bone since the introduction of osseointegration in the 1970s, is…
Read More » -
Hospitals
U.S. Surgitech Awarded Laparoscopic Surgical Instruments Agreement with Premier, Inc.
CAROL STREAM, Ill., Feb. 14, 2022 /PRNewswire/ — As of February 1, U.S. Surgitech has been awarded a three-year agreement with Premier, Inc.…
Read More » -
Biologics
Ortho Regenerative Technologies Enters Into A Material Transfer Agreement With A Global Strategic Medical Company For Its Ortho-R Rotator Cuff Tear Repair Phase I/II U.S. Clinical Trial
MONTREAL, Feb. 7, 2022 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (“Ortho” or the “Company“), a clinical-stage orthobiologics company focused on…
Read More »